During the last three months, 15 analysts shared their evaluations of Chewy CHWY, revealing diverse outlooks from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 9 | 3 | 2 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 1 | 0 | 0 | 0 |
| 2M Ago | 0 | 7 | 2 | 2 | 0 |
| 3M Ago | 0 | 1 | 1 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $31.2, a high estimate of $38.00, and a low estimate of $20.00. This current average reflects an increase of 17.91% from the previous average price target of $26.46.
Decoding Analyst Ratings: A Detailed Look
The analysis of recent analyst actions sheds light on the perception of Chewy by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Bill Kerr | TD Cowen | Announces | Buy | $38.00 | - |
| Peter Keith | Piper Sandler | Maintains | Overweight | $35.00 | $35.00 |
| Seth Basham | Wedbush | Maintains | Outperform | $35.00 | $35.00 |
| Doug Anmuth | JP Morgan | Raises | Overweight | $33.00 | $28.00 |
| Lauren Schenk | Morgan Stanley | Raises | Overweight | $33.00 | $30.00 |
| Steven Shemesh | RBC Capital | Raises | Outperform | $32.00 | $24.00 |
| Trevor Young | Barclays | Raises | Overweight | $34.00 | $32.00 |
| Michael Lasser | UBS | Raises | Neutral | $30.00 | $21.00 |
| Curtis Nagle | B of A Securities | Raises | Underperform | $24.00 | $20.00 |
| Mark Mahaney | Evercore ISI Group | Raises | In-Line | $29.00 | $22.00 |
| Lauren Schenk | Morgan Stanley | Raises | Overweight | $30.00 | $28.00 |
| Justin Kleber | Baird | Raises | Outperform | $32.00 | $26.00 |
| Curtis Nagle | B of A Securities | Raises | Underperform | $20.00 | $18.50 |
| Seth Basham | Wedbush | Maintains | Outperform | $35.00 | $35.00 |
| Steven Zaccone | Citigroup | Raises | Neutral | $28.00 | $16.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Chewy. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Chewy compared to the broader market.
- Price Targets: Gaining insights, analysts provide estimates for the future value of Chewy's stock. This comparison reveals trends in analysts' expectations over time.
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Chewy's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
Stay up to date on Chewy analyst ratings.
Get to Know Chewy Better
Chewy is the largest e-commerce pet care retailer in the US, generating $11.2 billion in 2023 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a stand-alone company in 2019 after spending a couple of years developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods, like crates, leashes, and bowls.
Key Indicators: Chewy's Financial Health
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: Chewy's remarkable performance in 3 months is evident. As of 31 July, 2024, the company achieved an impressive revenue growth rate of 2.63%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: Chewy's net margin excels beyond industry benchmarks, reaching 10.46%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Chewy's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 52.96%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Chewy's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 9.49% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.06.
The Basics of Analyst Ratings
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
